1. Home
  2. AAPG vs KN Comparison

AAPG vs KN Comparison

Compare AAPG & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAPG
  • KN
  • Stock Information
  • Founded
  • AAPG 2009
  • KN 1946
  • Country
  • AAPG China
  • KN United States
  • Employees
  • AAPG N/A
  • KN N/A
  • Industry
  • AAPG Biotechnology: Pharmaceutical Preparations
  • KN Consumer Electronics/Appliances
  • Sector
  • AAPG Health Care
  • KN Consumer Staples
  • Exchange
  • AAPG Nasdaq
  • KN Nasdaq
  • Market Cap
  • AAPG 2.2B
  • KN 1.8B
  • IPO Year
  • AAPG 2025
  • KN N/A
  • Fundamental
  • Price
  • AAPG $37.38
  • KN $17.21
  • Analyst Decision
  • AAPG Buy
  • KN Buy
  • Analyst Count
  • AAPG 1
  • KN 2
  • Target Price
  • AAPG N/A
  • KN $20.50
  • AVG Volume (30 Days)
  • AAPG 14.3K
  • KN 510.6K
  • Earning Date
  • AAPG 08-06-2025
  • KN 07-30-2025
  • Dividend Yield
  • AAPG N/A
  • KN N/A
  • EPS Growth
  • AAPG N/A
  • KN N/A
  • EPS
  • AAPG N/A
  • KN N/A
  • Revenue
  • AAPG $134,352,180.00
  • KN $552,400,000.00
  • Revenue This Year
  • AAPG N/A
  • KN $6.49
  • Revenue Next Year
  • AAPG $389.09
  • KN $5.68
  • P/E Ratio
  • AAPG N/A
  • KN N/A
  • Revenue Growth
  • AAPG 341.77
  • KN 23.91
  • 52 Week Low
  • AAPG $16.50
  • KN $12.19
  • 52 Week High
  • AAPG $37.95
  • KN $20.86
  • Technical
  • Relative Strength Index (RSI)
  • AAPG N/A
  • KN 56.46
  • Support Level
  • AAPG N/A
  • KN $16.73
  • Resistance Level
  • AAPG N/A
  • KN $17.28
  • Average True Range (ATR)
  • AAPG 0.00
  • KN 0.33
  • MACD
  • AAPG 0.00
  • KN -0.03
  • Stochastic Oscillator
  • AAPG 0.00
  • KN 63.22

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in three segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions, Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications and the Consumer MEMS Microphones segment designs and manufactures micro-electro-mechanical systems microphones and audio solutions used in applications. The majority of its revenue comes from the Consumer MEMS Microphones segment.

Share on Social Networks: